Literature DB >> 21788525

Reproducibility of CT perfusion parameters in liver tumors and normal liver.

Chaan S Ng1, Adam G Chandler, Wei Wei, Delise H Herron, Ella F Anderson, Razelle Kurzrock, Chusilp Charnsangavej.   

Abstract

PURPOSE: To assess the reproducibility of computed tomographic (CT) perfusion measurements in liver tumors and normal liver and effects of motion and data acquisition time on parameters.
MATERIALS AND METHODS: Institutional review board approval and written informed consent were obtained for this prospective study. The study complied with HIPAA regulations. Two CT perfusion scans were obtained 2-7 days apart in seven patients with liver tumors with two scanning phases (phase 1: 30-second breath-hold cine; phase 2: six intermittent free-breathing cines) spanning 135 seconds. Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area product (PS) for tumors and normal liver were calculated from phase 1 with and without rigid registration and, for combined phases 1 and 2, with manually and rigid-registered phase 2 images, by using deconvolution modeling. Variability was assessed with within-patient coefficients of variation (CVs) and Bland-Altman analyses.
RESULTS: For tumors, BF, BV, MTT, and PS values and reproducibility varied by analytical method, the former by up to 11%, 23%, 21%, and 138%, respectively. Median PS values doubled with the addition of phase 2 data to phase 1 data. The best overall reproducibility was obtained with rigidly registered phase 1 and phase 2 images, with within-patient CVs for BF, BV, MTT, and PS of 11.2%, 14.4%, 5.5% and 12.1%, respectively. Normal liver evaluations were similar, except with marginally lower variability.
CONCLUSION: Absolute values and reproducibility of CT perfusion parameters were markedly influenced by motion and data acquisition time. PS, in particular, probably requires data acquisition beyond a single breath hold, for which motion-correction techniques are likely necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788525      PMCID: PMC3156998          DOI: 10.1148/radiol.11110331

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Perfusion CT: a worthwhile enhancement?

Authors:  K A Miles; M R Griffiths
Journal:  Br J Radiol       Date:  2003-04       Impact factor: 3.039

2.  Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model.

Authors:  Errol E Stewart; Xaiogang Chen; Jennifer Hadway; Ting-Yim Lee
Journal:  Radiology       Date:  2006-04-18       Impact factor: 11.105

3.  Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility.

Authors:  Vicky Goh; Steve Halligan; Jo-Ann Hugill; Clive I Bartram
Journal:  AJR Am J Roentgenol       Date:  2006-07       Impact factor: 3.959

Review 4.  Body perfusion CT: technique, clinical applications, and advances.

Authors:  Avinash R Kambadakone; Dushyant V Sahani
Journal:  Radiol Clin North Am       Date:  2009-01       Impact factor: 2.303

5.  Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study.

Authors:  Errol E Stewart; Xiaogang Chen; Jennifer Hadway; Ting-Yim Lee
Journal:  Phys Med Biol       Date:  2008-07-24       Impact factor: 3.609

6.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps.

Authors:  A Cenic; D G Nabavi; R A Craen; A W Gelb; T Y Lee
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

7.  Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.

Authors:  Susan M Galbraith; Martin A Lodge; N Jane Taylor; Gordon J S Rustin; Søren Bentzen; J James Stirling; Anwar R Padhani
Journal:  NMR Biomed       Date:  2002-04       Impact factor: 4.044

8.  Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour.

Authors:  T G Purdie; E Henderson; T Y Lee
Journal:  Phys Med Biol       Date:  2001-12       Impact factor: 3.609

9.  Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.

Authors:  Bruno Morgan; Anne L Thomas; Joachim Drevs; Juergen Hennig; Martin Buchert; Asvina Jivan; Mark A Horsfield; Klaus Mross; Howard A Ball; Lucy Lee; William Mietlowski; Stefan Fuxuis; Clemens Unger; Ken O'Byrne; Andrew Henry; Graham R Cherryman; Dirk Laurent; Margaret Dugan; Dieter Marmé; William P Steward
Journal:  J Clin Oncol       Date:  2003-09-29       Impact factor: 44.544

10.  Reproducibility of quantitative CT perfusion imaging.

Authors:  J H Gillard; N M Antoun; N G Burnet; J D Pickard
Journal:  Br J Radiol       Date:  2001-06       Impact factor: 3.039

View more
  25 in total

1.  CTA combined with CT perfusion for assessing the efficacy of anti-angiogenic therapy in rabbit VX2 tumors.

Authors:  Han Wang; Lin-Feng Zheng; Yan Feng; Xue-Qian Xie; Xiao-Ming Yang; Gui-Xiang Zhang
Journal:  Acad Radiol       Date:  2012-03       Impact factor: 3.173

2.  A semi-automatic method for the extraction of the portal venous input function in quantitative dynamic contrast-enhanced CT of the liver.

Authors:  Andrew B Gill; Nicholas J Hilliard; Simon T Hilliard; Martin J Graves; David J Lomas; Ashley Shaw
Journal:  Br J Radiol       Date:  2017-06-20       Impact factor: 3.039

3.  Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver.

Authors:  Chaan S Ng; Adam G Chandler; Wei Wei; Ella F Anderson; Delise H Herron; Razelle Kurzrock; Chusilp Charnsangavej
Journal:  J Comput Assist Tomogr       Date:  2012 Jul-Aug       Impact factor: 1.826

4.  DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.

Authors:  Shimon Aronhime; Claudia Calcagno; Guido H Jajamovich; Hadrien Arezki Dyvorne; Philip Robson; Douglas Dieterich; M Isabel Fiel; Valérie Martel-Laferriere; Manjil Chatterji; Henry Rusinek; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

5.  Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).

Authors:  Thomas J Vogl; Patrik Schaefer; Thomas Lehnert; Nour-Eldin A Nour-Eldin; Hanns Ackermann; Emmanuel Mbalisike; Renate Hammerstingl; Katrin Eichler; Stephan Zangos; Nagy N N Naguib
Journal:  Eur Radiol       Date:  2015-06-27       Impact factor: 5.315

6.  Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.

Authors:  Osman Melih Topcuoğlu; Muşturay Karçaaltıncaba; Deniz Akata; Mustafa Nasuh Özmen
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

7.  Effect of sampling frequency on perfusion values in perfusion CT of lung tumors.

Authors:  Chaan S Ng; Adam G Chandler; Wei Wei; Ella F Anderson; Delise H Herron; Razelle Kurzrock; Chusilp Charnsangavej
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

Review 8.  CT perfusion of the liver: principles and applications in oncology.

Authors:  Se Hyung Kim; Aya Kamaya; Jürgen K Willmann
Journal:  Radiology       Date:  2014-08       Impact factor: 11.105

Review 9.  Optimal combination of antiangiogenic therapy for hepatocellular carcinoma.

Authors:  Hui-Ju Ch'ang
Journal:  World J Hepatol       Date:  2015-08-08

Review 10.  New approaches for precise response evaluation in hepatocellular carcinoma.

Authors:  Koichi Hayano; Jorge M Fuentes-Orrego; Dushyant V Sahani
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.